Exploring the Association between Epstein-Barr Virus and Systemic Lupus Erythematosus: Insights into Viral Triggers
Health and Metabolism · 2025
DOI: 10.53941/hm.2025.100012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health and Metabolism, 2025. Verfasst von Ling Zhong und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epstein-Barr virus (EBV) is ubiquitous in humans, which infects more than 90% of adults globally. Beyond its established association with malignancies, EBV infection is linked to several autoimmune diseases including systemic lupus erythematosus (SLE), multiple sclerosis (MS), rheumatoid arthritis and Sjögren syndrome. SLE is characterized by systemic inflammation and multiorgan damage with unpredictable relapsing-remitting clinical course. Although significant evidence supports EBV infection as a contributing factor in SLE pathogenesis, the exact mechanisms linking EBV to SLE onset remain to be fully elucidated. Molecular mimicry is among the potential factors that may drive SLE development. Importantly, given this association, development of therapies targeting EBV is promising for novel SLE treatment.
Zitieren
APA
Zhong, L., & Zhang, X. (2025). Exploring the Association between Epstein-Barr Virus and Systemic Lupus Erythematosus: Insights into Viral Triggers. Health and Metabolism. https://doi.org/10.53941/hm.2025.100012
Vancouver
Zhong L, Zhang X. Exploring the Association between Epstein-Barr Virus and Systemic Lupus Erythematosus: Insights into Viral Triggers. Health and Metabolism. 2025. doi:10.53941/hm.2025.100012
BibTeX
@article{Zhong2025,
author = {Zhong, Ling and Zhang, Xiao},
title = {Exploring the Association between Epstein-Barr Virus and Systemic Lupus Erythematosus: Insights into Viral Triggers},
journal = {Health and Metabolism},
year = {2025},
doi = {10.53941/hm.2025.100012}
}
EUVIMED